Endocannabinoid signalling in atherosclerosis and related metabolic complications

Endocannabinoids are a group of arachidonic acid-derived lipid mediators binding to cannabinoid receptors CB1 and CB2. An overactivity of the endocannabinoid system plays a pathophysiological role in the development of visceral obesity and insulin resistance. Moreover, elevated circulating endocanna...

Full description

Saved in:
Bibliographic Details
Main Authors: Guillamat-Prats, Raquel (Author) , Herzig, Stephan (Author)
Format: Article (Journal)
Language:English
Published: 15. Februar 2019
In: Thrombosis and haemostasis
Year: 2019, Volume: 119, Issue: 4, Pages: 567-575
ISSN:2567-689X
DOI:10.1055/s-0039-1678738
Online Access:Verlag, Volltext: https://doi.org/10.1055/s-0039-1678738
Verlag: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0039-1678738
Get full text
Author Notes:Raquel Guillamat-Prats, Martina Rami, Stephan Herzig, Sabine Steffens

MARC

LEADER 00000caa a2200000 c 4500
001 1688791574
003 DE-627
005 20231026105322.0
007 cr uuu---uuuuu
008 200129s2019 xx |||||o 00| ||eng c
024 7 |a 10.1055/s-0039-1678738  |2 doi 
035 |a (DE-627)1688791574 
035 |a (DE-599)KXP1688791574 
035 |a (OCoLC)1341299925 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Guillamat-Prats, Raquel  |e VerfasserIn  |0 (DE-588)1203744943  |0 (DE-627)1688792228  |4 aut 
245 1 0 |a Endocannabinoid signalling in atherosclerosis and related metabolic complications  |c Raquel Guillamat-Prats, Martina Rami, Stephan Herzig, Sabine Steffens 
264 1 |c 15. Februar 2019 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 29.01.2020 
520 |a Endocannabinoids are a group of arachidonic acid-derived lipid mediators binding to cannabinoid receptors CB1 and CB2. An overactivity of the endocannabinoid system plays a pathophysiological role in the development of visceral obesity and insulin resistance. Moreover, elevated circulating endocannabinoid levels are also prevalent in atherosclerosis. The pathophysiological increase of endocannabinoid levels is due to an altered expression of endocannabinoid synthesizing and degrading enzymes induced by inflammatory mediators such as cytokines or lipids. Emerging experimental evidence suggests that enhanced endocannabinoid signalling affects atherosclerosis via multiple effects, including a modulation of vascular inflammation, leukocyte recruitment, macrophage cholesterol metabolism and consequently atherosclerotic plaque stability. In addition, recent findings in various metabolic disease models highlight the relevance of peripheral CB1 cannabinoid receptors in adipose tissue, liver and pancreas, which crucially regulate lipid and glucose metabolism as well as macrophage properties in these organs. This suggests that targeting the endocannabinoid system in the vasculature and peripheral organs might have a therapeutic potential for atherosclerosis by inhibiting vascular inflammation and improving metabolic risk factors. This review will provide a brief update on the effects of endocannabinoid signalling in atherosclerosis and related metabolic complications. 
700 1 |a Herzig, Stephan  |d 1969-  |e VerfasserIn  |0 (DE-588)12146623X  |0 (DE-627)705470857  |0 (DE-576)292725949  |4 aut 
773 0 8 |i Enthalten in  |t Thrombosis and haemostasis  |d Stuttgart : Thieme, 1976  |g 119(2019), 4, Seite 567-575  |h Online-Ressource  |w (DE-627)302723188  |w (DE-600)1492370-1  |w (DE-576)079877362  |x 2567-689X  |7 nnas  |a Endocannabinoid signalling in atherosclerosis and related metabolic complications 
773 1 8 |g volume:119  |g year:2019  |g number:4  |g pages:567-575  |g extent:9  |a Endocannabinoid signalling in atherosclerosis and related metabolic complications 
856 4 0 |u https://doi.org/10.1055/s-0039-1678738  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.thieme-connect.de/DOI/DOI?10.1055/s-0039-1678738  |x Verlag 
951 |a AR 
992 |a 20200129 
993 |a Article 
994 |a 2019 
998 |g 12146623X  |a Herzig, Stephan  |m 12146623X:Herzig, Stephan  |d 50000  |e 50000PH12146623X  |k 0/50000/  |p 3 
999 |a KXP-PPN1688791574  |e 3583113977 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Raquel Guillamat-Prats, Martina Rami, Stephan Herzig, Sabine Steffens"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 29.01.2020"],"origin":[{"dateIssuedDisp":"15. Februar 2019","dateIssuedKey":"2019"}],"physDesc":[{"extent":"9 S."}],"relHost":[{"disp":"Endocannabinoid signalling in atherosclerosis and related metabolic complicationsThrombosis and haemostasis","language":["eng"],"id":{"eki":["302723188"],"issn":["2567-689X"],"zdb":["1492370-1"],"doi":["10.1055/s-00035024"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["35.1976 -"],"note":["Gesehen am 15.06.2018"],"origin":[{"dateIssuedDisp":"1976-","dateIssuedKey":"1976","publisherPlace":"Stuttgart ; Stuttgart","publisher":"Thieme ; Schattauer"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"pages":"567-575","issue":"4","extent":"9","text":"119(2019), 4, Seite 567-575","year":"2019","volume":"119"},"title":[{"title_sort":"Thrombosis and haemostasis","title":"Thrombosis and haemostasis","subtitle":"journal of the International Society on Thrombosis and Haemostasis"}],"recId":"302723188"}],"title":[{"title_sort":"Endocannabinoid signalling in atherosclerosis and related metabolic complications","title":"Endocannabinoid signalling in atherosclerosis and related metabolic complications"}],"language":["eng"],"id":{"eki":["1688791574"],"doi":["10.1055/s-0039-1678738"]},"person":[{"family":"Guillamat-Prats","role":"aut","roleDisplay":"VerfasserIn","given":"Raquel","display":"Guillamat-Prats, Raquel"},{"role":"aut","family":"Herzig","display":"Herzig, Stephan","roleDisplay":"VerfasserIn","given":"Stephan"}],"recId":"1688791574"} 
SRT |a GUILLAMATPENDOCANNAB1520